Publications by authors named "R Holman"

Claim this Profile
V
Validation of an algorithm for selection of SGLT2 and DPP4 inhibitor therapies in people with type 2 diabetes across major UK ethnicity groups: a retrospective cohort study.
Laura M Güdemann, Katherine G Young, Pedro Cardoso, Bilal A Mateen, Rury R Holman

Lancet Reg Health Eur· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Variation in Case Fatality After Major Coronary or Cerebrovascular Events in Individuals With Type 2 Diabetes: Evidence From ADVANCE, TECOS, and EXSCEL.
Philip M Clarke, Xinyang Hua, Ruth L Coleman, John Chalmers, Mark Woodward, Rury R Holman

Diabetes Care· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating the risk of cardiovascular outcomes and all-cause mortality in individuals with type 2 diabetes: Validation of the UKPDS outcomes model using TECOS and EXSCEL data.
Ruth L Coleman, Amanda I Adler, Philip M Clarke, Darren K McGuire, Rury R Holman

Diabetes Obes Metab· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical perspectives of new insights and tools to minimize the hypoglycaemia burden connected with type 2 diabetes pharmacotherapy.
Eberhard Standl, Antonio Ceriello, Darren K McGuire, Oliver Schnell, Rury R Holman

Cardiovasc Diabetol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of changes in conventional risk factors induced by once-weekly GLP-1 receptor agonist exenatide on cardiovascular outcomes: an EXSCEL post hoc analysis.
Ruth L Coleman, Amanda I Adler, Robert J Mentz, Marat Fudim, Naveed Sattar, Rury R Holman

Cardiovasc Diabetol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis